|
Market Closed -
Nasdaq
04:00:00 2026-08-24 pm EDT
|
5-day change | 1st Jan Change | ||
| 17.78 USD | -0.73% |
|
-3.47% | +41.11% |
| Market Cap | 5.68B 4.87B 4.55B 4.16B 7.85B 544B 7.94B 53.87B 20.95B 273B 21.32B 20.86B 903B | P/E 2026 * |
39.5x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.95B 6.81B 6.37B 5.83B 11B 761B 11.12B 75.43B 29.33B 382B 29.86B 29.21B 1,265B | EV / Sales 2026 * |
2.53x | EV / Sales 2027 * | 2.25x |
| Free-Float |
44.29% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Amneal Pharmaceuticals, Inc.
| 1 day | -0.73% | ||
| 1 week | -3.47% | ||
| Current month | -2.95% | ||
| 1 month | -0.78% | ||
| 3 months | +43.16% | ||
| 6 months | +21.28% | ||
| Current year | +41.11% |
| 1 week | 17.61 |  | 18.58 |
| 1 month | 16.77 | | 19.26 |
| Current year | 11.71 | | 19.26 |
| 1 year | 9.2 | | 19.26 |
| 3 years | 3.36 | | 19.26 |
| 5 years | 1.24 | | 19.26 |
| 10 years | 1.24 | | 24.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/13/26 | Sell | Director | -60,000 | 0.0188% | ||
| 8/12/26 | Sell | Head of Human Resources | -146,403 | 0.0458% | ||
| 8/12/26 | Sell | General Counsel | -210,000 | 0.0658% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.73% | -3.47% | +85.40% | +341.19% | 5.68B | |
| -0.67% | +5.39% | +75.21% | +127.54% | 1,111B | |
| +1.04% | +4.07% | +52.29% | +65.39% | 658B | |
| -0.17% | +5.67% | +25.60% | +80.40% | 467B | |
| +0.12% | +2.74% | +42.67% | +43.06% | 369B | |
| +0.12% | +1.15% | +25.44% | +41.55% | 301B | |
| +0.36% | +3.02% | +2.45% | +14.10% | 256B | |
| +1.03% | +5.83% | +51.11% | +72.96% | 240B | |
| +1.92% | +2.92% | -16.96% | -52.27% | 207B | |
| +0.42% | +5.63% | +27.86% | +92.24% | 182B | |
| Average | +0.01% | +3.70% | +37.11% | +82.62% | 379.67B | |
| Weighted average by Cap. | -0.14% | +4.67% | +44.33% | +73.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.15B 2.7B 2.52B 2.31B 4.35B 301B 4.4B 29.87B 11.61B 151B 11.82B 11.57B 501B | 3.41B 2.93B 2.74B 2.5B 4.72B 327B 4.77B 32.39B 12.59B 164B 12.82B 12.54B 543B |
| Net income | 149M 128M 119M 109M 206M 14.25B 208M 1.41B 549M 7.16B 559M 547M 23.67B | 295M 253M 236M 216M 408M 28.22B 412M 2.8B 1.09B 14.17B 1.11B 1.08B 46.89B |
| Net Debt | 2.27B 1.95B 1.82B 1.67B 3.14B 218B 3.18B 21.57B 8.39B 109B 8.54B 8.35B 362B | 2B 1.71B 1.6B 1.47B 2.77B 192B 2.8B 18.98B 7.38B 96.19B 7.51B 7.35B 318B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | $17.78 | -0.73% | 1,788,137 |
| 26-08-21 | $17.91 | +0.06% | 1,365,526 |
| 26-08-20 | $17.90 | -1.16% | 1,249,784 |
| 26-08-19 | $18.11 | -0.44% | 1,469,872 |
| 26-08-18 | $18.19 | -1.25% | 2,026,546 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRX Stock
Select your edition
All financial news and data tailored to specific country editions
